Reinfection, severe outcome more common with BA.5 variant; virus spike protein toxic to heart cells

Reinfection, severe outcome more common with BA.5 variant; virus spike protein toxic to heart cells

A medical worker administers a dose of the “Cominarty” Pfizer-BioNTech coronavirus disease (COVID-19) vaccine to a patient at a vaccination center in Ancenis-Saint-Gereon, France, November 17, 2021. REUTERS/Stephane Mahe/File Photo/File Photo Register now for FREE unlimited access to Reuters.com Register July 28 (Reuters) – The following is a summary of some recent studies on COVID-19. …

Reinfection, severe outcome more common with BA.5 variant; virus spike protein toxic to heart cells Read More »